Import Permit for Registration Samples in Russia Under Ministry of Health Order No. 661n

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

To import unregistered medical device samples for the purpose of state registration, an import permit is required under Order No. 661n of the Ministry of Health, dated 30 June 2020. The permit is single-use, valid for 1 year, and the approval step at the Ministry of Health takes about 5 working days. Without this permit, test samples cannot legally enter Russia, and neither technical testing nor clinical trials can start. The permit is therefore the true opening move of the Russian registration timetable: every downstream milestone, from bench testing to clinical evaluation, depends on samples being in the country and in the laboratory on schedule.

Because the permit is single-use and batch-specific, the logistics plan and the test plan must be settled before the application is filed. Quantities, models and batch identification stated in the permit must match the physical shipment, and any change to the test program after the permit has been issued may require a fresh application rather than an amendment. Teams that treat the permit as an administrative formality and file it late often lose weeks at the start of the project, which no later stage can recover. The permit also anchors the customs description of the goods: laboratories, brokers and the manufacturer all work from the same figures, so any drift between them is visible to the reviewer and to the border authorities.

2. Legal basis

The sample import permit operates alongside the general registration rules and the federal prohibition on circulating unregistered devices, with its own dedicated pathway. The table below lists the instruments relied on in this article, with reference numbers, dates and relevant provisions.

Legal actReferenceDateProvisions
Order of the Ministry of Health on the procedure for importing medical devices for the purpose of state registrationOrder of the Ministry of Health of Russia No. 661n30 June 2020permit application, approval and validity
Government Resolution of the Russian Federation on the National Rules for the State Registration of Medical DevicesGovernment Resolution No. 168430 November 2024para. 5 (technical testing, toxicological studies and clinical trials)
Federal Law on the Fundamentals of Protection of the Health of Citizens in the Russian FederationFederal Law No. 323-FZ21 November 2011Article 38 (prohibition and exceptions for unregistered devices)
Government Resolution of the Russian Federation on the rules for importing unregistered devicesGovernment Resolution No. 55716 May 2026 (in force from 1 September 2026)general rules for the import of unregistered devices

3. Expert insights

Insight one: the sample permit is a one-year, single-use authorization. It is issued for specific batches and quantities; it is not a pass valid for the whole registration period. If the test program extends beyond one year, a new permit is required. Projects should therefore be planned so that testing, sample consumption and the permit window align, and so that a second application can be prepared without panic if the program overruns. Shipping margin quantities within the permitted figures is a standard way to avoid a second import cycle.

Insight two: the sample permit and the general import of unregistered devices are not the same pathway. The reason the registration sample permit is granted smoothly is that the application states the registration purpose explicitly. If goods are actually intended for exhibition display or for clinical use outside the registration program, the appropriate import pathway must be selected according to that actual purpose. Using a registration sample permit as cover for other purposes exposes the shipment to challenge at customs and undermines the whole filing. Each import should be mapped to the pathway that matches its true purpose before shipment is booked.

Insight three: from 1 September 2026 the general import rules have been renewed. Government Resolution No. 557 replaces the previous rules and remains in force until 1 September 2032. Although the sample permit follows its own dedicated pathway under Order No. 661n, the practical execution of both regimes needs to be checked together, since the same shipments may involve documents, declarations and customs procedures touched by both frameworks. A compliance calendar that tracks only one of the two rules leaves blind spots in the import file.

Insight four: the 5-working-day approval is short but unforgiving. The approval window is brief, yet an application with inconsistent model names or quantities will be corrected rather than approved, and each correction restarts the clock. A pre-filing review of the permit application against the final shipping documents is the cheapest insurance available in this process.

4. Practical recommendations

The steps below keep the sample import track aligned with the testing timetable. They apply to any project that requires unregistered samples in Russian laboratories under the registration program.

  1. Start the permit application as soon as the test plan is settled, and build the 5 working days approval time into the project schedule.
  2. Keep the device names, models and quantities in the permit strictly identical to the physical shipment; any inconsistency invites customs questioning.
  3. After testing, retain records of sample disposition (retention, destruction or return) for later traceability.
  4. Where the test program may exceed one year, prepare the follow-up permit application before the first permit expires.
  5. Appoint one owner for the sample file, covering the permit, the customs documents and the disposition records, so the trail stays complete through the registration cycle.

5. Verification checklist

Confirm each item below before and after the sample shipment. The checklist covers the permit content, its validity and the parallel import frameworks.

  • □ The import permit for registration samples has been obtained under Order No. 661n
  • □ The names, models and quantities stated in the permit match the physical goods
  • □ The permit validity (1 year) covers the whole test program
  • □ Other import pathways that may apply under Government Resolution No. 557 have been checked
  • □ Sample disposition records have been archived

Regulatory information verified as of 29 October 2026.

GRZAN manages the import of registration samples for the Russian market: preparing and filing Order No. 661n permit applications, aligning permit content with shipping documents, coordinating customs clearance and maintaining the sample disposition archive for traceability. For support with a sample import program, contact GRZAN at info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail